Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Public ClinicalTrials.gov record NCT00981799. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Nelarabine has shown significant activity in patients with T-cell malignancies. This study will determine the safety and maximum tolerated dose of the combination of nelarabine, cyclophosphamide and etoposide in patients with first bone marrow relapse of T-ALL, or first relapse of T-LL.
Study identification
- NCT ID
- NCT00981799
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 23 participants
Conditions and interventions
Interventions
- Nelarabine Drug
- Etoposide Drug
- Cyclophosphamide Drug
- Methotrexate Drug
- Filgrastim Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Year to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2010 (Type not available)
- Primary completion
- Nov 2015 (Actual)
- Completion
- Jul 18, 2016 (Actual)
- Last update posted
- Oct 1, 2020
2010 – 2016
United States locations
- U.S. sites
- 26
- U.S. states
- 20
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Childrens Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Children's Hospital Orange County | Orange | California | — | — |
| UCSF School of Medicine | San Francisco | California | 94143-0106 | — |
| The Children's Hospital, University of Colorado | Aurora | Colorado | 80045 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | — | — |
| University of Miami Cancer Center | Miami | Florida | 33136 | — |
| Children's Healthcare of Atlanta, Emory University | Atlanta | Georgia | — | — |
| Lurie Children's Hospital | Chicago | Illinois | — | — |
| Johns Hopkins University | Baltimore | Maryland | — | — |
| Dana Farber | Boston | Massachusetts | — | — |
| C.S. Mott Children's Hospital | Ann Arbor | Michigan | 48109-0914 | — |
| Childrens Hospital & Clinics of Minnesota | Minneapolis | Minnesota | 55404-4597 | — |
| Children's Mercy Hospitals and Clinics | Kansas City | Missouri | 64108 | — |
| New York University Medical Center | New York | New York | 10016 | — |
| Children's Hospital New York-Presbyterian | New York | New York | 10032 | — |
| Levine Children's Hospital at Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Rainbow Babies | Cleveland | Ohio | — | — |
| Nationwide Childrens Hospital | Columbus | Ohio | — | — |
| Oregon Health and Science University | Portland | Oregon | — | — |
| St. Jude | Memphis | Tennessee | 38105-3678 | — |
| Vanderbilt Children's Hospital | Nashville | Tennessee | — | — |
| University of Texas at Southwestern | Dallas | Texas | — | — |
| Cook Children's Hospital | Fort Worth | Texas | — | — |
| Primary Children's | Salt Lake City | Utah | — | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00981799, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2020 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00981799 live on ClinicalTrials.gov.